The big story for Agile Therapeutics in Q3 was its preparation for an anticipated commercial launch of its Twirla contraceptive patch. Agile expanded its distribution network for Twirla during the quarter by signing a deal with its third major U.S. wholesaler.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,